Abstract
The surface of the cornea consists of a unique type of non-keratinized epithelial cells arranged in an orderly fashion, and this is essential for vision by maintaining transparency for light transmission. Cornea epithelial cells (CECs) undergo continuous renewal from limbal stem or progenitor cells (LSCs)1,2, and deficiency in LSCs or corneal epithelium—which turns cornea into a non-transparent, keratinized skin-like epithelium—causes corneal surface disease that leads to blindness in millions of people worldwide3. How LSCs are maintained and differentiated into corneal epithelium in healthy individuals and which key molecular events are defective in patients have been largely unknown. Here we report establishment of an in vitro feeder-cell-free LSC expansion and three-dimensional corneal differentiation protocol in which we found that the transcription factors p63 (tumour protein 63) and PAX6 (paired box protein PAX6) act together to specify LSCs, and WNT7A controls corneal epithelium differentiation through PAX6. Loss of WNT7A or PAX6 induces LSCs into skin-like epithelium, a critical defect tightly linked to common human corneal diseases. Notably, transduction of PAX6 in skin epithelial stem cells is sufficient to convert them to LSC-like cells, and upon transplantation onto eyes in a rabbit corneal injury model, these reprogrammed cells are able to replenish CECs and repair damaged corneal surface. These findings suggest a central role of the WNT7A–PAX6 axis in corneal epithelial cell fate determination, and point to a new strategy for treating corneal surface diseases.
Corneal and skin epithelium share many similarities, including a typical morphology of stratified epithelium and maintenance of their stem cells by p63 in the keratin 5/keratin 14+ (K5/K14)-expressing basal cell layer in limbus and epidermis4–8 (Fig. 1a, b and Extended Data Fig. 1a, b). However, there are marked differences between them. Skin epithelial stem cells (SESCs) move upwards from a deep to suprabasal layers vertically during differentiation9,10, where K5 and K14 are replaced by skin-specific K1 and K10 (ref. 11 and Extended Data Fig. 1c, d). In contrast, LSCs (defined by K19 at the limbus12, see Fig. 1a and Extended Data Fig. 1e) migrate centripetally for several millimetres to the central cornea during which it undergoes differentiation and K5/K14 are replaced by corneal-specific K3 and K12 (refs 13, 14, Fig. 1c and Extended Data Fig. 1f).
A clear, transparent cornea maintained by CECs is essential for vision. Pathological conversion of CECs into skin-like epithelial cells, as indicated by morphological changes and switches in keratin expression (for example, replacement of cornea-specific K3 and K12 by skin-specific K1 and K10 along with K5+ cells at the basal layer; see Fig. 1d), leads to the loss of transparency in the cornea and causes millions of people around the world to suffer from partial or complete blindness3, but the underlying mechanism has remained largely unknown.
To elucidate potential disease mechanisms, we successfully developed a feeder-free cell culture protocol to expand LSCs from human donors, enabling us to generate a homogeneous cell population to delineate key factors involved in controlling LSC cell fate determination and CEC differentiation. Proliferating LSCs were characterized by positive p63 and K19 with a high percentage of mitotic marker Ki67 (Fig. 2a and Extended Data Fig. 1g). We next established a three-dimensional LSC differentiation protocol to establish a three-dimensional CEC sphere structure from a single LSC within 14 to 18 days, as evidenced by strong expression of the CEC-specific markers K3 and K12 (Fig. 2b). The three-dimensional differentiation sphere was further characterized by key differences in gene expression between LSCs and CECs; the latter showed increased expression of K3 (31.2-fold higher) and K12 (24.7-fold higher) and concomitant decreased expression of K19 (6.2-fold lower, all P < 0.01; see Extended Data Fig. 1h). We took a similar strategy to expand SESCs and observed strong expression of typical SESC markers p63 and K5 in cultured SESCs (Fig. 2c). As expected, we detected increased expression of epidermal differentiation markers K1 (16.6-fold higher) and K10 (225.8-fold higher) in three-dimensional differentiated skin epithelial cells (SECs) compared to SESCs (Fig. 2d, Extended Data Fig. 1i, j).
To identify additional genes uniquely expressed in LSCs, CECs and SESCs, we performed genome-wide gene expression analysis (Fig. 2e and Extended Data Fig. 2a, b). Among genes that were differentially expressed, we focused on signalling molecules and transcription factors because of their central roles in cell fate determination and differentiation. We identified that WNT7A and PAX6 were highly expressed in LSCs and CECs when compared to SESCs (PAX6, 8.8-fold higher in LSCs and 12.3-fold higher in CECs, P < 0.001; WNT7A, 4.5-fold higher in LSCs, 6.0-fold higher in CECs, P < 0.001) (Fig. 2e and Extended Data Fig. 2c). We observed that WNT7A expression precisely mirrored the expression pattern of PAX6 in in vitro LSC and CEC cultures, and in in vivo epithelial layers of cornea and limbus from infant to adult, while both of these genes were undetectable in skin epidermis (Fig. 2f and Extended Data Fig. 2d).
To determine the clinical relevance of WNT7A and PAX6 expression in LSCs and CECs, we examined several types of human corneal diseases, corneal epithelium squamous metaplasia, inflammatory keratopathy, trauma and alkaline burn. We observed the localized expression of p63 and K5 at the basal layer (Fig. 3a and Extended Data Fig. 3), and the expression of K10 in the suprabasal layer (Fig. 1d and Extended Data Fig. 3). We also found that WNT7A and PAX6 expression, and K3 and K12 expression were conspicuously absent in areas of metaplasia, while they were positive in surrounding corneal epithelium (Fig. 3a and Extended Data Fig. 3). These results suggest cornea epithelial cells were switched to skin-like epithelial cells in patient tissues with these disease conditions.
Wnt molecules are secreted signalling proteins that have a critical role in controlling cell fate decisions and tissue specification15. PAX6 is also a well-known control gene for eye development and disease16. However, it has remained unclear whether the loss of PAX6 is the cause or the consequence of abnormal skin epidermal differentiation in ocular surface diseases.
To demonstrate that WNT7A and PAX6 are necessary for LSC and CEC cell fate determination and differentiation, we used lentiviral short hairpin RNAs (shRNAs) to knock them down specifically in LSCs. Although LSCs with knockdown of either WNT7A or PAX6 did not change proliferation and morphological properties (Extended Data Fig. 4a), these treatments significantly diminished the expression of corneal K3 and K12 under the three-dimensional differentiation conditions (WNT7A knockdown: 24.7-fold lower in K3, 22.6-fold lower in K12; PAX6 knockdown: 20.8-fold lower in K3, 21.4-fold lower in K12; all P < 0.05), and concurrently, the expression of skin-specific K1 and K10 became more prominent (WNT7A knockdown: 3.9-fold higher in K1 and 5.7-fold higher in K10; PAX6 knockdown: 3.1-fold higher K1 and 6.1-fold higher in K10; all P < 0.05), indicative of more skin-like differentiation (Fig. 3b, c). Moreover, knockdown of WNT7A reduced PAX6 expression in LSCs (1.8-fold lower, P < 0.001); this repressive effect was even stronger in differentiated CECs (8.0-fold lower, P < 0.01). In contrast, there was no significant difference in WNT7A expression when PAX6 was knocked down in either LSCs or CECs (Fig. 3c and Extended Data Fig. 4b, c). These results suggest that WNT7A acts upstream of PAX6 during CEC differentiation.
To study further the role of the Wnt signalling pathway in corneal fate determination and differentiation, we investigated the functional requirement of Frizzled receptors, which have been shown to interact and transduce WNT7A signalling based on co-immunoprecipitation17. We found that WNT7A interacted strongly with Frizzled 5 (FZD5) in LSCs (Extended Data Fig. 4d, e), and as predicted, knockdown of FZD5 in LSCs also led to reduced PAX6 expression (1.7-fold lower in LSCs and 3.0-fold lower in differentiated CECs (P < 0.001) (Extended Data Fig. 4f). Together, these data demonstrated that loss of WNT7A or PAX6 led to a switch of corneal epithelial cells to skin-like epidermal cells and that WNT7A and FZD5 acted as the upstream regulators of PAX6 expression in corneal differentiation.
Given the central role of PAX6 in eye development16, we next tested the possibility that engineered expression of PAX6 might be able to convert SESCs into LSC-like cells (Extended Data Fig. 5a). Indeed, we found that the expression of either PAX6a or PAX6b in SESCs was sufficient to convert them into LSC-like cells, as evidenced by the induced K19 expression on the surface, coincident with the expression of both p63 and PAX6 in the nucleus (Fig. 4a). When placed in three-dimensional culture, PAX6-transduced SESCs showed dramatic increase in corneal K3 and K12 expression (9.4-fold higher and 72.7-fold higher, all P < 0.05) with concomitant decrease in skin K1 and K10 expression (20.8-fold lower and 20.0-fold lower, all P < 0.01) (Fig. 4b, c and Extended Data Fig. 5b, c). To obtain global evidence for successful cell fate conversion, we performed gene expression profiling by RNA sequencing (RNA-seq)18 on CECs, SECs and LSCs after knocking down PAX6 and on SESCs transduced with PAX6 upon three-dimensional differentiation. We generated 3 to 7 million reads from each biological sample that were uniquely mapped to the RefSeq database (Extended Data Fig. 6a). Pairwise comparison demonstrated that the data were very reproducible within the same group of samples (Extended Data Fig. 6b); in contrast, when compared between cells with different fates, the data demonstrate remarkable differences based on the statistical cut-off of false discovery rate (FDR) < 0.001 (Extended Data Fig. 6c). We displayed the entire data sets that recorded the expression of >10,000 genes in various cell types (Fig. 4d), demonstrating that both induced (red) and repressed (green) genes were clearly co-segregated between CECs and PAX6+ SESCs and between PAX6 shRNA-treated LSCs and SECs. These data therefore provided global evidence for a role of the WNT7A–PAX6 axis in cell fate conversion from SESCs to CECs. Together, these data suggest that defects in the WNT7A–PAX6 axis are likely to be responsible for metaplastic conversion of corneal cells to skin epidermal-like cells in corneal diseases in humans (shown in Fig. 4e), although further studies need to be performed to determine the significance of the WNT7 and PAX6 axis in corneal epithelial differentiation.
Finally, we tested the treatment and repair potential of SESCs with engineered expression of PAX6 (Extended Data Fig. 7a–c) for corneal epithelial defects in a rabbit LSC deficiency model (Extended Data Fig. 7f), which mimics a common corneal disease condition in humans. We showed that rabbit SESCs with PAX6 transduction formed a continuous sheet of epithelial cells with positive staining of corneal-specific K3 and K12 (Fig. 5a) and successfully repaired epithelium defect of the entire corneal surface to restore and maintain normal cornea clarity and transparency for over 3 months (Fig. 5b–g and Extended Data Fig. 8). By following the time course of corneal epithelial surface repair using GFP-labelled PAX6+ SESCs, we observed that these PAX6-reprogrammed SESCs were initially only located at the limbal region and then moved progressively towards the central cornea with corresponding areas of restored cornea clarity (Extended Data Fig. 9a). Importantly, these grafted cells were indeed able to repopulate limbus as evidenced by culture and re-isolation of PAX6+ SESCs from limbal region (Extended Data Fig. 9b). Notably, these reprogrammed SESCs were capable of repairing large corneal epithelium defects after repeated corneal epithelial scraping (Extended Data Fig. 9c). In marked contrast, transplanting rabbit LSCs with PAX6 knockdown (Extended Data Fig. 7a, d, e) onto denuded corneal surface resulted in a K10+ skin-like epithelium with opacity and vascularization (Fig. 5f). Together, these data demonstrate that SESCs with PAX6 expression are able to trans-differentiate into corneal-like epithelium and repair corneal surface defects.
In summary, this work establishes the feasibility of expanding LSCs under feeder-free conditions and its therapeutic potential, and demonstrates key roles of WNT7A and PAX6 in corneal lineage specification. Importantly, SESCs or other cell types converted into a corneal fate by PAX6 expression may serve as a potential source for corneal surface repair and regeneration, particularly in patients with total LSC deficiency. This would overcome a major feasibility problem in using a patient’s own reprogrammed LSCs for transplantation, thus pointing to a potential therapeutic strategy for treating many common corneal diseases in humans.
METHODS SUMMARY
LSCs and SESCs were isolated from rabbits and human donors in feeder-free media and differentiated in the three-dimensional culture conditions. Histology, immunohistochemistry and immunocytochemistry were carried out on paraffin sections as well as on cultured cells. Gene expression microarray, RNA-seq and quantitative PCR (qPCR) were performed using total RNA isolated from LSCs, SESCs and CECs. Lentiviral RNA interference and engineered-expression study of WNT7A, PAX6 and FZD5 were carried out in LSCs and SESCs. Cell transplantation of LSCs and SESCs was performed on animal models of corneal injury. Detailed information is provided in the supplement.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
Extended Data
Extended Data Table 1.
Extended Data Table 1a. Primer sequences
| ||
---|---|---|
Gene (Human) | Forward Primer | Reverse Primer |
CASZ1 | GTTCTACGGACAGAAGACCACG | TCTTGAAGCCGTCCTTGGCGTA |
FGFR3 | AGTGGAGCCTGGTCATGGAA | GGATGCTGCCAAACTTGTTCTC |
FZD5 | TGGAACGCTTCCGCTATCCTGA | GGTCTCGTAGTGGATGTGGTTG |
GAPDH | GAGTCAACGGATTTGGTCGT | GACAAGCTTCCCGTTCTCAG |
ID2 | TTGTCAGCCTGCATCACCAGAG | AGCCACACAGTGCTTTGCTGTC |
K1 | CAGCATCATTGCTGAGGTCAAGG | CATGTCTGCCAGCAGTGATCTG |
K3 | ACGTGACTACCAGGAGCTGATG | ATGCTGACAGCACTCGGACACT |
K5 | GCTGCCTACATGAACAAGGTGG | ATGGAGAGGACCACTGAGGTGT |
K10 | CCTGCTTCAGATCGACAATGCC | ATCTCCAGGTCAGCCTTGGTCA |
K12 | AGCAGAATCGGAAGGACGCTGA | ACCTCGCTCTTGCTGGACTGAA |
K14 | TGCCGAGGAATGGTTCTTCACC | GCAGCTCAATCTCCAGGTTCTG |
K15 | AGGACTGACCTGGAGATGCAGA | TGCGTCCATCTCCACATTGACC |
K19 | AGCTAGAGGTGAAGATCCGCGA | GCAGGACAATCCTGGAGTTCTC |
MEIS1 | AAGCAGTTGGCACAAGACACGG | CTGCTCGGTTGGACTGGTCTAT |
MMP9 | GCCACTACTGTGCCTTTGAGTC | CCCTCAGAGAATCGCCAGTACT |
MMP10 | TCCAGGCTGTATGAAGGAGAGG | GGTAGGCATGAGCCAAACTGTG |
NR2F2 | TGCACGTTGACTCAGCCGAGTA | AAGCACACTGAGACTTTTCCTGC |
NOTCH1 | GGTGAACTGCTCTGAGGAGATC | GGATTGCAGTCGTCCACGTTGA |
NOTCH3 | TACTGGTAGCCACTGTGAGCAG | CAGTTATCACCATTGTAGCCAGG |
ODZ3 | GGACAAGGCTATCACAGTGGAC | TTCTGAGGGAGCCGTCATAACC |
PAX6 | TGTCCAACGGATGTGTGAGT | TTTCCCAAGCAAAGATGGAC |
PDGFA | CAGCGACTCCTGGAGATAGACT | CGATGCTTCTCTTCCTCCGAATG |
PPARG | AGCCTGCGAAAGCCTTTTGGTG | GGCTTCACATTCAGCAAACCTGG |
PRDM8 | CTGTGTCCTGAGCCATACTTCC | CCTTCTGAGGAACCATTTGCTGC |
TGFBI | AGGACTGACGGAGACCCTCAAC | TCCGCTAACCAGGATTTCATCAC |
WNT7A | TGCCCGGACTCTCATGAAC | GTGTGGTCCAGCACGTCTTG |
| ||
Gene (Rabbit) | Forward Primer | Reverse Primer |
| ||
GAPDH | GCGAGATCCCGCCAACATCAAGT | AGGATGCGTTGCTGACAATC |
PAX6 | GTATTCTTGCTTCAGGTAGAT | GAGGCTCAAATGCGACTTCAGCT |
| ||
Primers used for PAX6 transduction | ||
| ||
PAX6 InF | TTCCCGAATTCTGCAGACCCATGCAGATGCAAAAGTCCAAGTGCTGGACAATCAAAACGTGTCCAACGGATGTG | |
PAX6 InR | CACATCCGTTGGACACGTTTTGATTGTCCAGCACTTGGACTTTTGCATCTGCATGGGTCTGCAGAATTCGGGAA |
Extended Data Table 1b. Summary of rabbit transplantation results
| |||
---|---|---|---|
Rabbit number | |||
| |||
GFP-labeled donor cells | Regeneration and re-epithelization | Opaque and vascularized corneal surface | Died from systemic infection or unrelated complications |
LSCs | 3 | 0 | 0 |
PAX6+ SESCs | 5 | 0 | 2 |
shPAX6 LSCs | 0 | 4 | 1 |
a, Primer sequences for human and rabbit genes used in this study. b, Corneal regeneration and re-epithelization were arrayed three months after transplantation.
Supplementary Material
Acknowledgments
This study is supported in part by the 973 program (2013CB967504 and 2014CB964900), Project of Fundamental Research Funds (no.2012KF03), State Key laboratory of Ophthalmology, NIH (GM049369), KACST-UCSD Center of Excellence in Nanomedicine, NIH Director’s Transformative RO1 Program (R01 EY021374) and CIRM.
Footnotes
Author Contributions H.O., X.-D.F., Yiz. L., and K.Z. designed study, interpreted data and wrote the manuscript. H.O., Y.X., Yin. L., X.Z., L.X., H.C., J.L., Mei. Z., Min. Z., Y.Y., H.L., G.L., E.Y., G.C., J.Z. and B.Y. performed the experiments. Y.L., W.J., J.L. and Yiz. L. obtained human samples. S.C., S.P., M.P. and L.Z. contributed to data analysis and interpretation.
Microarray and RNA sequence information has been submitted to the Gene Expression Omnibus database under accession number GSE32145 and GSE54322.
The authors declare no competing financial interests.
Readers are welcome to comment on the online version of the paper.
References
- 1.Davanger M, Evensen A. Role of the pericorneal papillary structure in renewal of corneal epithelium. Nature. 1971;229:560–561. doi: 10.1038/229560a0. [DOI] [PubMed] [Google Scholar]
- 2.Cotsarelis G, Cheng SZ, Dong G, Sun TT, Lavker RM. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell. 1989;57:201–209. doi: 10.1016/0092-8674(89)90958-6. [DOI] [PubMed] [Google Scholar]
- 3.Li W, et al. Down-regulation of Pax6 is associated with abnormal differentiation of corneal epithelial cells in severe ocular surface diseases. J Pathol. 2008;214:114–122. doi: 10.1002/path.2256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Pellegrini G, et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA. 2001;98:3156–3161. doi: 10.1073/pnas.061032098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Mills AA, et al. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 1999;398:708–713. doi: 10.1038/19531. [DOI] [PubMed] [Google Scholar]
- 6.Yang A, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999;398:714–718. doi: 10.1038/19539. [DOI] [PubMed] [Google Scholar]
- 7.Koster MI, Kim S, Mills AA, DeMayo FJ, Roop DR. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev. 2004;18:126–131. doi: 10.1101/gad.1165104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Rama P, et al. Limbal stem-cell therapy and long-term corneal regeneration. N Engl J Med. 2010;363:147–155. doi: 10.1056/NEJMoa0905955. [DOI] [PubMed] [Google Scholar]
- 9.Blanpain C, Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nature Rev Mol Cell Biol. 2009;10:207–217. doi: 10.1038/nrm2636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Arwert EN, Hoste E, Watt FM. Epithelial stem cells, wound healing and cancer. Nature Rev Cancer. 2012;12:170–180. doi: 10.1038/nrc3217. [DOI] [PubMed] [Google Scholar]
- 11.Kopan R, Fuchs E. A new look into an old problem: keratins as tools to investigate determination, morphogenesis, and differentiation in skin. Genes Dev. 1989;3:1–15. doi: 10.1101/gad.3.1.1. [DOI] [PubMed] [Google Scholar]
- 12.Lauweryns B, van den Oord JJ, Missotten L. The transitional zone between limbus and peripheral cornea. An immunohistochemical study. Invest Ophthalmol Vis Sci. 1993;34:1991–1999. [PubMed] [Google Scholar]
- 13.Eichner R, Bonitz P, Sun TT. Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression. J Cell Biol. 1984;98:1388–1396. doi: 10.1083/jcb.98.4.1388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Schlötzer-Schrehardt U, Kruse FE. Identification and characterization of limbal stem cells. Exp Eye Res. 2005;81:247–264. doi: 10.1016/j.exer.2005.02.016. [DOI] [PubMed] [Google Scholar]
- 15.Dorsky RI, Moon RT, Raible DW. Control of neural crest cell fate by the Wnt signalling pathway. Nature. 1998;396:370–373. doi: 10.1038/24620. [DOI] [PubMed] [Google Scholar]
- 16.Eiraku M, et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature. 2011;472:51–56. doi: 10.1038/nature09941. [DOI] [PubMed] [Google Scholar]
- 17.von Maltzahn J, Bentzinger CF, Rudnicki MA. Wnt7a-Fzd7 signalling directly activates the Akt/mTOR anabolic growth pathway in skeletal muscle. Nature Cell Biol. 2012;14:186–191. doi: 10.1038/ncb2404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Yu FX, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150:780–791. doi: 10.1016/j.cell.2012.06.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.